Article
[Clinical impact of gene mutations on myeloproliferative neoplasms in Japan].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2021
Morishita Soji
Abstract excerpt
Myeloproliferative neoplasms (MPN) are caused by somatic mutations in hematopoietic stem/progenitor cells and result in excessive increase in the blood cell mass in the peripheral blood and/or fibrosis in the bone marrow. JAK2, CALR, and MPL mutations are well-known driver mutations of MPN and are widely applied as diagnostic markers of MPN. Moreover, several studies using massive parallel sequencing technologies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
